10h
24/7 Wall St. on MSNMy 3 Top Picks for Stocks That Could Double Over the Next 3 YearsFinding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...
Eli Lilly strengthens its pipeline with AdvanCell for targeted alpha therapies and partners with OliX to advance OLX75016 for MASH and cardiometabolic diseases.
OliX Pharmaceuticals announced a global licensing agreement with Eli Lilly (LLY). This collaboration focuses on the development and ...
The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...
Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...
Uber stock is lower Wednesday as the ride-hailing firm's soft first-quarter outlook offsets its strong fourth-quarter results ...
Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...
Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid ...
Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.
We recently compiled a list of the 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...
The Alzheimer’s Association advised against diagnosing the disease on biomarkers alone, but other experts said the genie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results